Your Messages Inbox
Your Article Summary
See Latest ArticlesRapid reduction versus abrupt quitting for smokers who want to stop soon: a randomised controlled non-inferiority trial
Trials, 08/18/09
Lindson N et al. – The primary outcome of interest will be prolonged abstinence from smoking, with secondary trial outcomes of point prevalence, urges to smoke and withdrawal symptoms. Follow up will take place at 4 weeks, 8 weeks and 6 months post–quit day.
Related Articles
A cluster-randomized effectiveness trial of smoking cessation modified for at-risk smoker subgroups
Journal of Substance Abuse Treatment, 10/14/09
Relevance Score: 91%
Association of Serum TSH with High Body Mass Differs between Smokers and Never-Smokers
Journal of Clinical Endocrinology and Metabolism, 10/29/09
Relevance Score: 89%
A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers
Postgraduate Medical Journal, 10/08/09
Relevance Score: 89%
Secondhand Smoke and Respiratory Symptoms Among Adolescent Current Smokers
Pediatrics, 10/28/09
Relevance Score: 87%
Smoker interest in lower harm alternatives to cigarettes: National survey data
Nicotine & Tobacco Research, 10/16/09
Relevance Score: 87%
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Autologous blood therapy for common cold—A randomized, double-blind, placebo-controlled trial
Complementary Therapies in Medicine, 12/08/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Cytokinetics Presents Non-Clinical Data Relating To CK-2017357 At The 5th Cachexia Conference
Cytokinetics, 12/08/09
Article Search
Sponsor